I. Cousineau

发表

BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.

Abdellah Belmaaza, I. Cousineau, Christine Abaji, 2005, Cancer research.

Measurement of CD73 enzymatic activity using luminescence-based and colorimetric assays.

Kathleen M Spring, I. Cousineau, J. Stagg, 2019, Methods in enzymology.

Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasis

L. Buisseret, D. Allard, P. Chrobak, 2019, Oncoimmunology.

CD 73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer

Deena M. A. Gendoo, Kathleen M Spring, Gregory M. Chen, 2015 .

Prognostic value of CD73 expression in resected colorectal cancer liver metastasis

Franck Vandenbroucke-Menu, S. Turcotte, A. Roy, 2020, Oncoimmunology.

Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial

C. Sotiriou, S. Loi, K. Willard-Gallo, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

MSH 2-deficient Human Cells Exhibit a Defect in the Accurate Termination of Homology-directed Repair of DNA Double-Strand Breaks 1

I. Cousineau, Christine Abaji, A. Belmaaza, 2003 .

Disruption of p53 by the Viral oncoprotein HPV16-E6 does not Deregulate Chromosomal Homologous Recombination in a Transcriptional Interference-Free Assay System

I. Cousineau, Christine Abaji, A. Belmaaza, 2005, Cell cycle.

BRCA2 regulates homologous recombination in response to DNA damage: implications for genome stability and carcinogenesis.

I. Cousineau, Christine Abaji, A. Belmaaza, 2005, Cancer research.

EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases

I. Cousineau, A. Belmaaza, 2011, Molecular Genetics and Genomics.

BRCA1 Haploinsufficiency, but not Heterozygosity for a BRCA1-truncating Mutation, Deregulates Homologous Recombination

I. Cousineau, A. Belmaaza, 2007, Cell cycle.

CD73 is associated with poor prognosis in high-grade serous ovarian cancer.

Deena M. A. Gendoo, Kathleen M Spring, Gregory M. Chen, 2015, Cancer research.

Cohesion , Genome Stability , and Carcinogenesis Replication Slippage : Implications for Sister Chromatid Damage and Suppresses Spontaneous Sister Chromatid BRCA 1 Regulates RAD 51 Function in Response to DNA

I. Cousineau, Christine Abaji, A. Belmaaza, 2005 .

MSH2-deficient human cells exhibit a defect in the accurate termination of homology-directed repair of DNA double-strand breaks.

I. Cousineau, Christine Abaji, A. Belmaaza, 2003, Cancer research.

High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer

A. Mes-Masson, D. Provencher, L. Buisseret, 2021, Journal for ImmunoTherapy of Cancer.

Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns

P. Vermeulen, Franck Vandenbroucke-Menu, S. Turcotte, 2022, British Journal of Cancer.

Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns

P. Vermeulen, Franck Vandenbroucke-Menu, S. Turcotte, 2022, British Journal of Cancer.

Interleukin-27 signaling serves as an immunological checkpoint for innate cytotoxic cells to promote hepatocellular carcinoma.

X. Wang, A. Dzutsev, G. Trinchieri, 2022, Cancer discovery.

Prognostic value of CD73 expression in resected colorectal cancer liver metastasis.

A. Mes-Masson, Franck Vandenbroucke-Menu, S. Turcotte, 2018 .

Abstract 4550: Increased IL-27 is associated with poor prognosis in renal cell carcinoma and supports use of SRF388, a first-in-class IL-27p28 blocking antibody, to counteract IL-27-mediated immunosuppression in this setting

D. Moodley, Benjamin H. Lee, V. Palombella, 2020 .

CD73 inhibits cGAS-STING and cooperates with CD39 to promote pancreatic cancer.

Benjamin Haibe-Kains, S. Turcotte, D. Allard, 2022, Cancer immunology research.

The CD73 immune checkpoint promotes tumor cell metabolic fitness

E. Ma, D. Allard, I. Cousineau, 2022, bioRxiv.

Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma

L. Buisseret, D. Allard, P. Chrobak, 2023, Cell reports. Medicine.